TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2621342
log Bayes Factor = 106.925
Chromosome 6   position 32,775,004  (GRCh37) Explore rs2621342 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E10.9 Without complications
0.000 0.000 1.000
J45.9 Asthma, unspecified
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
L40.5 Arthropathic psoriasis
1.000 0.000 0.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
L40 Psoriasis
1.000 0.000 0.000
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
E10.1 With ketoacidosis
0.000 0.001 0.999
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.001 0.999
E10-E14 Diabetes mellitus
0.000 0.001 0.999
E10.3 With ophthalmic complications
0.000 0.003 0.997
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.003 0.997
E05.9 Thyrotoxicosis, unspecified
0.000 0.008 0.992
I25 Chronic ischaemic heart disease
0.990 0.010 0.000
I25.8 Other forms of chronic ischaemic heart disease
0.990 0.010 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.015 0.985
C44 Other malignant neoplasms of skin
0.985 0.015 0.000
C44.2 Skin of ear and external auricular canal
0.984 0.016 0.000
I20-I25 Ischaemic heart diseases
0.983 0.017 0.000
C44.7 Skin of lower limb, including hip
0.978 0.022 0.000
E10.4 With neurological complications
0.000 0.022 0.978
E16 Other disorders of pancreatic internal secretion
0.000 0.024 0.976
I25.9 Chronic ischaemic heart disease, unspecified
0.971 0.029 0.000
I21 Acute myocardial infarction
0.971 0.029 0.000
C44.3 Skin of other and unspecified parts of face
0.969 0.031 0.000
E16.2 Hypoglycaemia, unspecified
0.000 0.033 0.967
I21.2 Acute transmural myocardial infarction of other sites
0.953 0.047 0.000
C44.4 Skin of scalp and neck
0.946 0.054 0.000
E10.2 With renal complications
0.000 0.062 0.938
I24 Other acute ischaemic heart diseases
0.930 0.070 0.000
I21.9 Acute myocardial infarction, unspecified
0.924 0.076 0.000
E10.8 With unspecified complications
0.000 0.092 0.908
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.100 0.900
I25.2 Old myocardial infarction
0.880 0.120 0.000
I21.1 Acute transmural myocardial infarction of inferior wall
0.878 0.122 0.000
I24.8 Other forms of acute ischaemic heart disease
0.868 0.132 0.000
E07 Other disorders of thyroid
0.000 0.134 0.866
E10.0 With coma
0.000 0.136 0.864
E10.6 With other specified complications
0.000 0.148 0.852
L40.1 Generalised pustular psoriasis
0.843 0.157 0.000
E40-E46 Malnutrition
0.000 0.160 0.840
L40.0 Psoriasis vulgaris
0.839 0.161 0.000
I23 Certain current complications following acute myocardial infarction
0.838 0.162 0.000
E14 Unspecified diabetes mellitus
0.000 0.170 0.830
I22 Subsequent myocardial infarction
0.829 0.171 0.000
I24.9 Acute ischaemic heart disease, unspecified
0.819 0.181 0.000
I25.3 Aneurysm of heart
0.815 0.185 0.000
L40.4 Guttate psoriasis
0.814 0.186 0.000
C44.5 Skin of trunk
0.806 0.194 0.000
I22.1 Subsequent myocardial infarction of inferior wall
0.797 0.203 0.000
L40.8 Other psoriasis
0.781 0.219 0.000
C44.0 Skin of lip
0.773 0.227 0.000
E10.5 With peripheral circulatory complications
0.000 0.241 0.759
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.253 0.747
E07.9 Disorder of thyroid, unspecified
0.000 0.261 0.739
E14.3 With ophthalmic complications
0.000 0.262 0.738
I23.2 Ventricular septal defect as current complication following acute myocardial infarction
0.730 0.270 0.000
E46 Unspecified protein-energy malnutrition
0.000 0.273 0.727
E03.1 Congenital hypothyroidism without goitre
0.000 0.278 0.722
E10.7 With multiple complications
0.000 0.283 0.717
L40.2 Acrodermatitis continua
0.717 0.283 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.283 0.717
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.284 0.716
E16.1 Other hypoglycaemia
0.000 0.285 0.715
I25.6 Silent myocardial ischaemia
0.709 0.290 0.000
E15 Nondiabetic hypoglycaemic coma
0.000 0.293 0.706
C44.8 Overlapping lesion of skin
0.706 0.294 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.300 0.700
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.300 0.700
E16.4 Abnormal secretion of gastrin
0.000 0.300 0.700
E16.3 Increased secretion of glucagon
0.000 0.300 0.700
I21.X Presumed acute myicardial infaction (unconfirmed)
0.696 0.304 0.000
C44.9 Malignant neoplasm of skin, unspecified
0.687 0.313 0.000
E14.8 With unspecified complications
0.000 0.318 0.682
E07.8 Other specified disorders of thyroid
0.000 0.320 0.680
I21.3 Acute transmural myocardial infarction of unspecified site
0.670 0.330 0.000
E03.8 Other specified hypothyroidism
0.000 0.351 0.649
J45 Asthma
0.000 0.357 0.643
L40.3 Pustulosis palmaris et plantaris
0.641 0.358 0.000
I24.1 Dressler's syndrome
0.628 0.372 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.375 0.625
I25.4 Coronary artery aneurysm
0.624 0.376 0.000
E05.8 Other thyrotoxicosis
0.000 0.376 0.623
E07.1 Dyshormogenetic goitre
0.000 0.379 0.621
E07.0 Hypersecretion of calcitonin
0.000 0.379 0.621
I23.8 Other current complications following acute myocardial infarction
0.610 0.390 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.397 0.602
E45 Retarded development following protein-energy malnutrition
0.000 0.397 0.602
E43 Unspecified severe protein-energy malnutrition
0.000 0.397 0.602
E42 Marasmic kwashiorkor
0.000 0.397 0.602
E41 Nutritional marasmus
0.000 0.397 0.602
E40 Kwashiorkor
0.000 0.397 0.602
E14.6 With other specified complications
0.000 0.397 0.602
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction
0.601 0.399 0.000
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction
0.601 0.399 0.000
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction
0.601 0.399 0.000
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
0.601 0.399 0.000
I23.1 Atrial septal defect as current complication following acute myocardial infarction
0.601 0.399 0.000
I23.0 Haemopericardium as current complication following acute myocardial infarction
0.601 0.399 0.000
K90 Intestinal malabsorption
0.000 0.402 0.598
E14.7 With multiple complications
0.000 0.405 0.595
E14.2 Withrenal complications
0.000 0.405 0.595
E14.0 With coma
0.000 0.405 0.595
I24.0 Coronary thrombosis not resulting in myocardial infarction
0.595 0.405 0.000
E14.5 With peripheral circulatory complications
0.000 0.408 0.592
E50-E64 Other nutritional deficiencies
0.000 0.415 0.585
I25.0 Atherosclerotic cardiovascular disease, so described
0.585 0.415 0.000
E14.1 With ketoacidosis
0.000 0.419 0.581
I22.8 Subsequent myocardial infarction of other sites
0.580 0.420 0.000
J45.0 Predominantly allergic asthma
0.000 0.430 0.570
I25.5 Ischaemic cardiomyopathy
0.568 0.432 0.000
E65-E68 Obesity and other hyperalimentation
0.000 0.443 0.556
C44.1 Skin of eyelid, including canthus
0.553 0.447 0.000
I25.1 Atherosclerotic heart disease
0.548 0.452 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.455 0.545
I22.0 Subsequent myocardial infarction of anterior wall
0.539 0.461 0.000
L40-L45 Papulosquamous disorders
0.527 0.473 0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E12.9 Without complications
0.000 0.486 0.513
E12.8 With unspecified complications
0.000 0.486 0.513
E12.7 With multiple complications
0.000 0.486 0.513
E12.6 With other specified complications
0.000 0.486 0.513
E12.5 With peripheral circulatory complications
0.000 0.486 0.513
E12.4 With neurological complications
0.000 0.486 0.513
E12.3 With ophthalmic complications
0.000 0.486 0.513
E12.2 With renal complications
0.000 0.486 0.513
E12.1 With ketoacidosis
0.000 0.486 0.513
E12.0 With coma
0.000 0.486 0.513
E14.9 Without complications
0.000 0.493 0.507
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.493 0.507
E14.4 With neurological complications
0.000 0.512 0.488
E13 Other specified diabetes mellitus
0.000 0.515 0.485
K90.8 Other intestinal malabsorption
0.000 0.528 0.472
E53 Deficiency of other B group vitamins
0.000 0.539 0.461
J45.8 Mixed asthma
0.000 0.539 0.461
J45.1 Nonallergic asthma
0.000 0.539 0.461
I20 Angina pectoris
0.451 0.549 0.000
E44.1 Mild protein-energy malnutrition
0.000 0.568 0.432
E44.0 Moderate protein-energy malnutrition
0.000 0.568 0.432
K90.3 Pancreatic steatorrhoea
0.000 0.571 0.429
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.571 0.429
K90.1 Tropical sprue
0.000 0.571 0.429
E61 Deficiency of other nutrient elements
0.000 0.578 0.422
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.580 0.420
E63 Other nutritional deficiencies
0.000 0.580 0.420
E56 Other vitamin deficiencies
0.000 0.580 0.420
E50 Vitamin A deficiency
0.000 0.580 0.420
E60 Dietary zinc deficiency
0.000 0.580 0.420
E59 Dietary selenium deficiency
0.000 0.580 0.420
E54 Ascorbic acid deficiency
0.000 0.580 0.420
E52 Niacin deficiency [pellagra]
0.000 0.580 0.420
E51 Thiamine deficiency
0.000 0.584 0.416
E67 Other hyperalimentation
0.000 0.601 0.399
E68 Sequelae of hyperalimentation
0.000 0.601 0.399
L43 Lichen planus
0.399 0.601 0.000
E66 Obesity
0.000 0.603 0.397
L41 Parapsoriasis
0.396 0.603 0.000
L42 Pityriasis rosea
0.391 0.609 0.000
K90.9 Intestinal malabsorption, unspecified
0.000 0.619 0.381
E66.8 Other obesity
0.000 0.621 0.379
L44 Other papulosquamous disorders
0.378 0.622 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.378 0.622 0.000
E53.8 Deficiency of other specified B group vitamins
0.000 0.623 0.377
E58 Dietary calcium deficiency
0.000 0.630 0.370
C44.6 Skin of upper limb, including shoulder
0.360 0.640 0.000
I20.1 Angina pectoris with documented spasm
0.354 0.646 0.000
I20.0 Unstable angina
0.351 0.649 0.000
E13.8 With unspecified complications
0.000 0.652 0.348
E13.7 With multiple complications
0.000 0.652 0.348
E13.6 With other specified complications
0.000 0.652 0.348
E13.5 With peripheral circulatory complications
0.000 0.652 0.348
E13.4 With neurological complications
0.000 0.652 0.348
E13.2 With renal complications
0.000 0.652 0.348
E13.1 With ketoacidosis
0.000 0.652 0.348
E13.0 With coma
0.000 0.652 0.348
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.335 0.665 0.000
L43.9 Lichen planus, unspecified
0.334 0.666 0.000
E06 Thyroiditis
0.001 0.669 0.330
E53.1 Pyridoxine deficiency
0.000 0.669 0.331
E53.0 Riboflavin deficiency
0.000 0.669 0.331
E53.9 Vitamin B deficiency, unspecified
0.000 0.677 0.323
E61.2 Magnesium deficiency
0.000 0.685 0.315
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.314 0.686 0.000
L41.1 Pityriasis lichenoides chronica
0.303 0.697 0.000
E61.9 Deficiency of nutrient element, unspecified
0.000 0.697 0.302
E61.8 Deficiency of other specified nutrient elements
0.000 0.697 0.302
E61.7 Deficiency of multiple nutrient elements
0.000 0.697 0.302
E61.6 Vanadium deficiency
0.000 0.697 0.302
E61.5 Molybdenum deficiency
0.000 0.697 0.302
E61.4 Chromium deficiency
0.000 0.697 0.302
E61.3 Manganese deficiency
0.000 0.697 0.302
E61.0 Copper deficiency
0.000 0.697 0.302
E50.9 Vitamin A deficiency, unspecified
0.000 0.699 0.301
E50.8 Other manifestations of vitamin A deficiency
0.000 0.699 0.301
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.699 0.301
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.699 0.301
E50.5 Vitamin A deficiency with night blindness
0.000 0.699 0.301
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.699 0.301
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.699 0.301
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.699 0.301
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.699 0.301
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.699 0.301
E56.9 Vitamin deficiency, unspecified
0.000 0.699 0.301
E56.8 Deficiency of other vitamins
0.000 0.699 0.301
E56.1 Deficiency of vitamin K
0.000 0.699 0.301
E56.0 Deficiency of vitamin E
0.000 0.699 0.301
E63.9 Nutritional deficiency, unspecified
0.000 0.699 0.301
E63.8 Other specified nutritional deficiencies
0.000 0.699 0.301
E63.1 Imbalance of constituents of food intake
0.000 0.699 0.301
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.699 0.301
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.699 0.301
E64.8 Sequelae of other nutritional deficiencies
0.000 0.699 0.301
E64.3 Sequelae of rickets
0.000 0.699 0.301
E64.2 Sequelae of vitamin C deficiency
0.000 0.699 0.301
E64.1 Sequelae of vitamin A deficiency
0.000 0.699 0.301
E64.0 Sequelae of protein-energy malnutrition
0.000 0.699 0.301
C82.0 Small cleaved cell, follicular
0.300 0.700 0.000
E13.3 With ophthalmic complications
0.001 0.701 0.298
E51.9 Thiamine deficiency, unspecified
0.000 0.701 0.298
E51.8 Other manifestations of thiamine deficiency
0.000 0.701 0.298
E51.1 Beriberi
0.000 0.701 0.298
E51.2 Wernicke's encephalopathy
0.000 0.705 0.295
E61.1 Iron deficiency
0.000 0.709 0.291
E67.8 Other specified hyperalimentation
0.000 0.714 0.286
E67.3 Hypervitaminosis D
0.000 0.714 0.286
E67.2 Megavitamin-B6 syndrome
0.000 0.714 0.286
E67.1 Hypercarotenaemia
0.000 0.714 0.286
E67.0 Hypervitaminosis A
0.000 0.714 0.286
L43.3 Subacute (active) lichen planus
0.286 0.714 0.000
L43.2 Lichenoid drug reaction
0.286 0.714 0.000
L43.1 Bullous lichen planus
0.286 0.714 0.000
L43.0 Hypertrophic lichen planus
0.286 0.714 0.000
E66.1 Drug-induced obesity
0.000 0.715 0.285
E55 Vitamin D deficiency
0.000 0.715 0.284
L41.9 Parapsoriasis, unspecified
0.284 0.715 0.000
L41.8 Other parapsoriasis
0.284 0.715 0.000
L41.5 Retiform parapsoriasis
0.284 0.715 0.000
L41.4 Large plaque parapsoriasis
0.284 0.715 0.000
L41.3 Small plaque parapsoriasis
0.284 0.715 0.000
L41.2 Lymphomatoid papulosis
0.284 0.715 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.284 0.715 0.000
L44.9 Papulosquamous disorder, unspecified
0.271 0.729 0.000
L44.8 Other specified papulosquamous disorders
0.271 0.729 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.271 0.729 0.000
L44.3 Lichen ruber moniliformis
0.271 0.729 0.000
L44.2 Lichen striatus
0.271 0.729 0.000
L44.1 Lichen nitidus
0.271 0.729 0.000
L44.0 Pityriasis rubra pilaris
0.271 0.729 0.000
C82.2 Large cell, follicular
0.257 0.743 0.000
I21.4 Acute subendocardial myocardial infarction
0.253 0.747 0.000
C82.3 Follicular lymphoma grade IIIa
0.251 0.749 0.000
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.750 0.249
C82.1 Mixed small cleaved and large cell, follicular
0.244 0.756 0.000
E65 Localised adiposity
0.001 0.757 0.243
L43.8 Other lichen planus
0.238 0.762 0.000
E06.4 Drug-induced thyroiditis
0.001 0.763 0.237
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.001 0.763 0.237
E06.1 Subacute thyroiditis
0.001 0.763 0.237
E06.0 Acute thyroiditis
0.001 0.763 0.237
C82.4 Follicular lymphoma grade IIIb
0.234 0.766 0.000
I20.9 Angina pectoris, unspecified
0.233 0.767 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.229 0.771 0.000
C82.6 Cutaneous follicle centre lymphoma
0.225 0.775 0.000
C82.5 Diffuse follicle centre lymphoma
0.225 0.775 0.000
E66.0 Obesity due to excess calories
0.000 0.779 0.221
M07.3 Other psoriatic arthropathies
0.220 0.780 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.220 0.780 0.000
E06.5 Other chronic thyroiditis
0.001 0.782 0.218
C43-C44 Melanoma and other malignant neoplasms of skin
0.216 0.784 0.000
E13.9 Without complications
0.000 0.785 0.214
M07.30 Other psoriatic arthropathies (Multiple sites)
0.213 0.787 0.000
I22.9 Subsequent myocardial infarction of unspecified site
0.209 0.791 0.000
E55.0 Rickets, active
0.000 0.796 0.204
M07.36 Other psoriatic arthropathies (Lower leg)
0.192 0.808 0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.190 0.810 0.000
M07.34 Other psoriatic arthropathies (Hand)
0.179 0.821 0.000
E06.9 Thyroiditis, unspecified
0.001 0.835 0.164
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.164 0.836 0.000
M07.31 Other psoriatic arthropathies (Shoulder region)
0.161 0.839 0.000
M07.38 Other psoriatic arthropathies (Other)
0.158 0.842 0.000
M07.33 Other psoriatic arthropathies (Forearm)
0.158 0.842 0.000
M07.32 Other psoriatic arthropathies (Upper arm)
0.158 0.842 0.000
E06.3 Autoimmune thyroiditis
0.001 0.893 0.106
I21.0 Acute transmural myocardial infarction of anterior wall
0.104 0.896 0.000
T43.2 Other and unspecified antidepressants
0.103 0.897 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.098 0.902 0.000
T42.4 Benzodiazepines
0.097 0.903 0.000
W19.9 Unspecified place
0.000 0.904 0.096
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.094 0.906 0.000
M07 Psoriatic and enteropathic arthropathies
0.093 0.907 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.091 0.909 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.090 0.910 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.089 0.911 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.083 0.917 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.080 0.920 0.000
T42.3 Barbiturates
0.077 0.923 0.000
I20.8 Other forms of angina pectoris
0.076 0.924 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.076 0.924 0.000
E66.9 Obesity, unspecified
0.000 0.927 0.073
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.072 0.928 0.000
T43.9 Psychotropic drug, unspecified
0.070 0.930 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.070 0.930 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.070 0.930 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.069 0.931 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.069 0.931 0.000
T42.0 Hydantoin derivatives
0.069 0.931 0.000
E55.9 Vitamin D deficiency, unspecified
0.000 0.931 0.069
T42.5 Mixed antiepileptics, not elsewhere classified
0.068 0.932 0.000
T42.2 Succinimides and oxazolidinediones
0.068 0.932 0.000
M07.6 Other enteropathic arthropathies
0.067 0.933 0.000
M07.5 Arthropathy in ulcerative colitis
0.067 0.933 0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]
0.067 0.933 0.000
M07.2 Psoriatic spondylitis
0.067 0.933 0.000
M07.1 Arthritis mutilans
0.067 0.933 0.000
M07.0 Distal interphalangeal psoriatic arthropathy
0.067 0.933 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.066 0.934 0.000
T42.1 Iminostilbenes
0.066 0.934 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.066 0.934 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.064 0.935 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.064 0.935 0.000
T36 Poisoning by systemic antibiotics
0.064 0.936 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.063 0.936 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.062 0.938 0.000
T50.7 Analeptics and opioid receptor antagonists
0.060 0.940 0.000
T50.5 Appetite depressants
0.060 0.940 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.060 0.940 0.000
T50.1 Loop [high-ceiling] diuretics
0.060 0.940 0.000
T50.0 Mineralocorticoids and their antagonists
0.060 0.940 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.059 0.941 0.000
T50.4 Drugs affecting uric acid metabolism
0.058 0.942 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.058 0.942 0.000
T50.8 Diagnostic agents
0.058 0.942 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.058 0.942 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.058 0.942 0.000
C43 Malignant melanoma of skin
0.057 0.943 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.054 0.945 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.054 0.946 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.054 0.946 0.000
E04 Other non-toxic goitre
0.001 0.947 0.052
T43.6 Psychostimulants with abuse potential
0.053 0.947 0.000
T47.2 Stimulant laxatives
0.052 0.948 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.052 0.948 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.051 0.949 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.050 0.950 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.050 0.950 0.000
T47.7 Emetics
0.050 0.950 0.000
T47.6 Antidiarrhoeal drugs
0.050 0.950 0.000
T47.5 Digestants
0.050 0.950 0.000
T47.4 Other laxatives
0.050 0.950 0.000
T47.3 Saline and osmotic laxatives
0.050 0.950 0.000
T47.0 Histamine H(2)-receptor antagonists
0.050 0.950 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.050 0.950 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.050 0.950 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.050 0.950 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.050 0.950 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.050 0.950 0.000
T44.0 Anticholinesterase agents
0.050 0.950 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.050 0.950 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.049 0.951 0.000
T36.3 Macrolides
0.049 0.951 0.000
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)
0.048 0.952 0.000
M07.08 Distal interphalangeal proriatic arthropathy-Other
0.048 0.952 0.000
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)
0.048 0.952 0.000
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg
0.048 0.952 0.000
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh
0.048 0.952 0.000
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)
0.048 0.952 0.000
M07.03 Distal interphalangeal proriatic arthropathy-Forearm
0.048 0.952 0.000
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm
0.048 0.952 0.000
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region
0.048 0.952 0.000
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)
0.048 0.952 0.000
M07.19 Arthritis mutilans (Site unspecified)
0.048 0.952 0.000
M07.18 Arthritis mutilans (Other)
0.048 0.952 0.000
M07.17 Arthritis mutilans (Ankle and foot)
0.048 0.952 0.000
M07.16 Arthritis mutilans (Lower leg)
0.048 0.952 0.000
M07.15 Arthritis mutilans (Pelvic region and thigh)
0.048 0.952 0.000
M07.14 Arthritis mutilans (Hand)
0.048 0.952 0.000
M07.13 Arthritis mutilans (Forearm)
0.048 0.952 0.000
M07.12 Arthritis mutilans (Upper arm)
0.048 0.952 0.000
M07.11 Arthritis mutilans (Shoulder region)
0.048 0.952 0.000
M07.10 Arthritis mutilans (Multiple sites)
0.048 0.952 0.000
M07.29 Psoriatic spondylitis (Site unspecified)
0.048 0.952 0.000
M07.28 Psoriatic spondylitis (Other)
0.048 0.952 0.000
M07.27 Psoriatic spondylitis (Ankle and foot)
0.048 0.952 0.000
M07.26 Psoriatic spondylitis (Lower leg)
0.048 0.952 0.000
M07.25 Psoriatic spondylitis (Pelvic region and thigh)
0.048 0.952 0.000
M07.24 Psoriatic spondylitis (Hand)
0.048 0.952 0.000
M07.23 Psoriatic spondylitis (Forearm)
0.048 0.952 0.000
M07.22 Psoriatic spondylitis (Upper arm)
0.048 0.952 0.000
M07.21 Psoriatic spondylitis (Shoulder region)
0.048 0.952 0.000
M07.20 Psoriatic spondylitis (Multiple sites)
0.048 0.952 0.000
M07.49 Arthropathy in Crohn's disease [regional enteritis] (Site unspecified)
0.048 0.952 0.000
M07.48 Arthropathy in Crohn's disease [regional enteritis] (Other)
0.048 0.952 0.000
M07.47 Arthropathy in Crohn's disease [regional enteritis] (Ankle and foot)
0.048 0.952 0.000
M07.46 Arthropathy in Crohn's disease [regional enteritis] (Lower leg)
0.048 0.952 0.000
M07.45 Arthropathy in Crohn's disease [regional enteritis] (Pelvic region and thigh)
0.048 0.952 0.000
M07.44 Arthropathy in Crohn's disease [regional enteritis] (Hand)
0.048 0.952 0.000
M07.43 Arthropathy in Crohn's disease [regional enteritis] (Forearm)
0.048 0.952 0.000
M07.42 Arthropathy in Crohn's disease [regional enteritis] (Upper arm)
0.048 0.952 0.000
M07.41 Arthropathy in Crohn's disease [regional enteritis] (Shoulder region)
0.048 0.952 0.000
M07.40 Arthropathy in Crohn's disease [regional enteritis] (Multiple sites)
0.048 0.952 0.000
M07.59 Arthropathy in ulcerative colitis (Site unspecified)
0.048 0.952 0.000
M07.58 Arthropathy in ulcerative colitis (Other)
0.048 0.952 0.000
M07.57 Arthropathy in ulcerative colitis (Ankle and foot)
0.048 0.952 0.000
M07.56 Arthropathy in ulcerative colitis (Lower leg)
0.048 0.952 0.000
M07.55 Arthropathy in ulcerative colitis (Pelvic region and thigh)
0.048 0.952 0.000
M07.54 Arthropathy in ulcerative colitis (Hand)
0.048 0.952 0.000
M07.53 Arthropathy in ulcerative colitis (Forearm)
0.048 0.952 0.000
M07.52 Arthropathy in ulcerative colitis (Upper arm)
0.048 0.952 0.000
M07.51 Arthropathy in ulcerative colitis (Shoulder region)
0.048 0.952 0.000
M07.50 Arthropathy in ulcerative colitis (Multiple sites)
0.048 0.952 0.000
M07.69 Other enteropathic arthropathies (Site unspecified)
0.048 0.952 0.000
M07.68 Other enteropathic arthropathies (Other)
0.048 0.952 0.000
M07.67 Other enteropathic arthropathies (Ankle and foot)
0.048 0.952 0.000
M07.66 Other enteropathic arthropathies (Lower leg)
0.048 0.952 0.000
M07.65 Other enteropathic arthropathies (Pelvic region and thigh)
0.048 0.952 0.000
M07.64 Other enteropathic arthropathies (Hand)
0.048 0.952 0.000
M07.63 Other enteropathic arthropathies (Forearm)
0.048 0.952 0.000
M07.62 Other enteropathic arthropathies (Upper arm)
0.048 0.952 0.000
M07.61 Other enteropathic arthropathies (Shoulder region)
0.048 0.952 0.000
M07.60 Other enteropathic arthropathies (Multiple sites)
0.048 0.952 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.048 0.952 0.000
T48.5 Anti-common-cold drugs
0.048 0.952 0.000
T48.4 Expectorants
0.048 0.952 0.000
T48.3 Antitussives
0.048 0.952 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.048 0.952 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.048 0.952 0.000
T48.0 Oxytocic drugs
0.048 0.952 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.048 0.952 0.000
T37.5 Antiviral drugs
0.048 0.952 0.000
T37.4 Anthelminthics
0.048 0.952 0.000
T37.3 Other antiprotozoal drugs
0.048 0.952 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.048 0.952 0.000
T37.1 Antimycobacterial drugs
0.048 0.952 0.000
T37.0 Sulphonamides
0.048 0.952 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.047 0.952 0.000
T45.0 Antiallergic and antiemetic drugs
0.047 0.953 0.000
T41.5 Therapeutic gases
0.046 0.953 0.000
T41.4 Anaesthetic, unspecified
0.046 0.953 0.000
T41.3 Local anaesthetics
0.046 0.953 0.000
T41.2 Other and unspecified general anaesthetics
0.046 0.953 0.000
T41.1 Intravenous anaesthetics
0.046 0.953 0.000
T41.0 Inhaled anaesthetics
0.046 0.953 0.000
T49.9 Topical agent, unspecified
0.046 0.953 0.000
T49.8 Other topical agents
0.046 0.953 0.000
T49.7 Dental drugs, topically applied
0.046 0.953 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.046 0.953 0.000
T49.5 Ophthalmological drugs and preparations
0.046 0.953 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.046 0.953 0.000
T49.3 Emollients, demulcents and protectants
0.046 0.953 0.000
T49.2 Local astringents and local detergents
0.046 0.953 0.000
T49.1 Antipruritics
0.046 0.953 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.046 0.953 0.000
C43.4 Malignant melanoma of scalp and neck
0.046 0.954 0.000
T36.9 Systemic antibiotic, unspecified
0.046 0.954 0.000
T36.8 Other systemic antibiotics
0.046 0.954 0.000
T36.7 Antifungal antibiotics, systemically used
0.046 0.954 0.000
T36.6 Rifamycins
0.046 0.954 0.000
T36.5 Aminoglycosides
0.046 0.954 0.000
T36.4 Tetracyclines
0.046 0.954 0.000
T36.2 Chloramphenicol group
0.046 0.954 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.046 0.954 0.000
C43.3 Malignant melanoma of other and unspecified parts of face
0.046 0.954 0.000
T38.1 Thyroid hormones and substitutes
0.044 0.956 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.043 0.957 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.042 0.958 0.000
T45.8 Other primarily systemic and haematological agents
0.042 0.958 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.042 0.958 0.000
T45.6 Fibrinolysis-affecting drugs
0.042 0.958 0.000
T45.4 Iron and its compounds
0.042 0.958 0.000
T45.3 Enzymes, not elsewhere classified
0.042 0.958 0.000
T38.9 Other and unspecified hormone antagonists
0.042 0.958 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.042 0.958 0.000
T38.7 Androgens and anabolic congeners
0.042 0.958 0.000
T38.5 Other oestrogens and progestogens
0.042 0.958 0.000
T38.4 Oral contraceptives
0.042 0.958 0.000
T38.2 Antithyroid drugs
0.042 0.958 0.000
T38.0 Glucocorticoids and synthetic analogues
0.042 0.958 0.000
C43.8 Overlapping malignant melanoma of skin
0.041 0.959 0.000
C43.0 Malignant melanoma of lip
0.041 0.959 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.041 0.959 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.